Research that Identifies
Undiscovered Value in the MicroCap Market



BOXLIGHT CORPORATION

Boxlight Corporation Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC Filings

Report Link: Updated Research Report (Dated 08/21/2019)

Symbol: BOXL
Analyst: John Nobile
Taglich Rating: Speculative Buy
Price Target: $5.50
Time Horizon: 12 Months
Rating Established: March 15, 2018
Price When Established: $4.00
Most Recent Report: August 21, 2019
Price When Issued: $2.45


What's New

Boxlight Reports 3Q19 Financial Results

On November 12, 2019, Boxlight Corporation (NASDAQ: BOXL) reported results for its third quarter ended September 30, 2019.

The company reported 3Q19 revenue increased 13.8% to $11.6 million from $10.2 million. Boxlight reported a net loss of $294,000 or $(0.03) per share versus a loss of $1.2 million or $(0.12) per share in 3Q18. Included in the loss for 3Q19 was a $1.4 million or $0.13 per share gain related to the change in fair value of derivative liabilities. Included in the loss for 3Q18 was an $822,000 or $0.08 per share gain related to the change in fair value of derivative liabilities. Excluding these items, Boxlight would have reported a net loss of $1.7 million or $(0.16) per share in 3Q19 and a loss of $2 million or $(0.20) per share in 3Q18.

Taglich Brothers projected 3Q19 revenue of $15 million and net income of $219,000 or $0.02 per share.


Company Description

Boxlight Corporation, headquartered in Lawrenceville, Georgia, is a designer, producer, and distributor of interactive classroom technologies for the global education market.


Company Reports

Updated Research Report (Dated August 21, 2019)

Updated Research Report (Dated May 28, 2019)

Updated Research Report (Dated April 5, 2019)

Updated Research Report (Dated December 5, 2018)

Updated Research Report (Dated September 6, 2018)

Updated Research Report (Dated May 30, 2018)

Initial Research Report (Dated March 15, 2018)


Disclaimer

Please view our current disclosure and disclaimer on our most recent research report.